CHC Healthcare Valuation
| 4164 Stock | TWD 44.45 1.40 3.25% |
At this time, the firm appears to be overvalued. CHC Healthcare Group owns a latest Real Value of NT$41.5 per share. The recent price of the firm is NT$44.45. Our model approximates the value of CHC Healthcare Group from examining the firm fundamentals such as return on asset of 0.0265, and Shares Outstanding of 161.54 M as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CHC Healthcare's price fluctuation is very steady at this time. Calculation of the real value of CHC Healthcare Group is based on 3 months time horizon. Increasing CHC Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CHC stock is determined by what a typical buyer is willing to pay for full or partial control of CHC Healthcare Group. Since CHC Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CHC Stock. However, CHC Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 44.45 | Real 41.5 | Hype 44.45 | Naive 44.43 |
The intrinsic value of CHC Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CHC Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CHC Healthcare Group helps investors to forecast how CHC stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CHC Healthcare more accurately as focusing exclusively on CHC Healthcare's fundamentals will not take into account other important factors: CHC Healthcare Total Value Analysis
CHC Healthcare Group is presently anticipated to have takeover price of 10.86 B with market capitalization of 8.59 B, debt of 3.89 B, and cash on hands of 1.3 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CHC Healthcare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.86 B | 8.59 B | 3.89 B | 1.3 B |
CHC Healthcare Investor Information
About 42.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.23. In the past many companies with similar price-to-book ratios have beat the market. CHC Healthcare Group last dividend was issued on the 13th of July 2022. The entity had 791:787 split on the 1st of December 2015. Based on the measurements of operating efficiency obtained from CHC Healthcare's historical financial statements, CHC Healthcare Group is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.CHC Healthcare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CHC Healthcare has an asset utilization ratio of 19.41 percent. This indicates that the Company is making NT$0.19 for each dollar of assets. An increasing asset utilization means that CHC Healthcare Group is more efficient with each dollar of assets it utilizes for everyday operations.CHC Healthcare Ownership Allocation
CHC Healthcare Group secures a total of 161.54 Million outstanding shares. CHC Healthcare Group shows serious amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.CHC Healthcare Profitability Analysis
The company reported the revenue of 2.44 B. Net Income was 381.63 M with profit before overhead, payroll, taxes, and interest of 849.48 M.About CHC Healthcare Valuation
Our relative valuation model uses a comparative analysis of CHC Healthcare. We calculate exposure to CHC Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CHC Healthcare's related companies.CHC Healthcare Group, through its subsidiaries, engages in the distribution, repair and maintenance, and lease of the medical equipment and related parts, consumables, and medicines in Taiwan, China, and internationally. The company was founded in 1977 and is headquartered in Taipei City, Taiwan. CHC HEALTHCARE is traded on Taiwan Stock Exchange in Taiwan.
8 Steps to conduct CHC Healthcare's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CHC Healthcare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CHC Healthcare's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CHC Healthcare's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CHC Healthcare's revenue streams: Identify CHC Healthcare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CHC Healthcare's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CHC Healthcare's growth potential: Evaluate CHC Healthcare's management, business model, and growth potential.
- Determine CHC Healthcare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CHC Healthcare's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for CHC Stock Analysis
When running CHC Healthcare's price analysis, check to measure CHC Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CHC Healthcare is operating at the current time. Most of CHC Healthcare's value examination focuses on studying past and present price action to predict the probability of CHC Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CHC Healthcare's price. Additionally, you may evaluate how the addition of CHC Healthcare to your portfolios can decrease your overall portfolio volatility.